EGFR/VEGFR2-IN-9
EGFR/VEGFR2-IN-9 (Compound 9b) is an inhibitor of VEGFR-2 (IC50 = 1.325 μM) and EGFR (IC50 = 1.891 μM). EGFR/VEGFR2-IN-9 significantly inhibits the proliferation of multiple cancer cell lines, particularly leukemia cells. EGFR/VEGFR2-IN-9 upregulates the expression levels of Bax, caspase-3, and p53, while downregulating the expression of Bcl-2. EGFR/VEGFR2-IN-9 induces apoptosis and arrests the cell cycle in the G1 phase. EGFR/VEGFR2-IN-9 can be used to investigate anti-tumor angiogenesis and multi-drug resistant cancers.
For research use only. We do not sell to patients.
- Formula: C25H23ClN6O3
- Molecular Weight:490.94
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
EGFR 1.891 μM (IC50) |
Bax |
Caspase 3 |
Bcl-2 |
Chemical Information
-
Molecular Weight 490.94
-
Formula C25H23ClN6O3
-
SMILES
COC(C=C12)=C(OC)C=C1N=CN=C2NC(C=C3)=CC=C3/C(C)=N/NC(NC4=CC=C(Cl)C=C4)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
EGFR/VEGFR2-IN-9 Related Classifications
HY-178942 Related Classifications
Powered by Bioz